Lv5
845 积分 2024-05-14 加入
Programmed Death-Ligand 1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Nonsquamous Versus Squamous NSCLC
4小时前
已完结
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
5小时前
已完结
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
6小时前
已完结
AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers
1个月前
已完结
Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non‐small cell lung cancer
1个月前
已完结
AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers
1个月前
已完结
Exploration of Fully‐Automated Body Composition Analysis Using Routine CT‐Staging of Lung Cancer Patients for Survival Prognosis
1个月前
已完结
Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
1个月前
已完结
Explanation of the obesity paradox of immunotherapy in cancer patients using CT-derived adipose composition parameters: A systematic review and meta-analysis
3个月前
已完结
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
3个月前
已完结
皖公网安备34019202002308
